Skip to main content

Table 1 Clinical, anthropometric, and fasting biochemical characteristics of participants based on BMI and bariatric surgery status

From: The impact of metabolic endotoxaemia on the browning process in human adipocytes

 

Lean

Overweight

Obese

Pre-Surgery

Post-Surgery

n

44

49

63

26

26

Age (years)

32.07 ± 1.2

31.56 ± 1.4

39.93 ± 1.7***####

54.50 ± 3.41

54.50 ± 3.41

BMI (Kg/m2)

22.14 ± 0.7

27.30 ± 0.8****

36.35 ± 1.0****####

42.21 ± 3.24

36.70 ± 3.14++++

Glucose (mmol/l)

3.58 ± 0.1

3.63 ± 0.1

5.92 ± 0.4****####

9.22 ± 1.57

6.96 ± 0.83++++

LDL (mmol/l)

4.56 ± 0.2

4.46 ± 0.2

3.82 ± 0.2**#

3.08 ± 0.54

2.67 ± 0.40+

HDL (mmol/l)

1.74 ± 0.1

1.53 ± 0.1

1.35 ± 0.1****

1.08 ± 0.16

1.04 ± 0.18

TGs (mmol/l)

3.11 ± 0.2

3.26 ± 0.1

2.65 ± 0.2#

1.83 ± 0.65

1.39 ± 0.40+

Insulin (pmol/l)

39.79 ± 4.3

64.58 ± 6.3*

62.97 ± 5.9*

31.90 ± 11.26

17.16 ± 5.49++++

  1. Selected pertinent clinical, anthropometric and fasting biochemical characteristics of the study participants based on body mass index (BMI) and bariatric surgery status; participants with (i) BMI: 18.5–24.9 kg/m2, (lean: n = 44); (ii) BMI: 25–29.9 kg/m2 (overweight: n = 49); and (iii) BMI: > 30 kg/m2 (obese: n = 63). Data are presented as mean ± SEM. All samples were taken in a fasted state. One-way ANOVA or the Kruskal–Wallis test were used to test significance between group comparisons; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 for lean vs. overweight and lean vs. obese, # p < 0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001 for overweight vs. obese. Significant differences between measurements taken pre- and 6 months post-bariatric surgery were assessed using two-tailed paired T-Test or Wilcoxon signed ranks test; +p < 0.05, ++p < 0.01, +++p < 0.001, ++++p < 0.0001
  2. BMI Body mass index, TGs Triglycerides, LDL Low-density lipoprotein, HDL High-density lipoprotein